Risk factors for development of hip disorder among newborn babies in Tesanj region

Seid Fazlagic1, Predrag Grubor, Suad Fazlagic

  • 1Department of Surgery, General Hospital Tesanj, Bosnia and Herzegovina. Fazlagics@gmail.com

Medicinski Arhiv
|January 12, 2011
PubMed

Insights

Developmental dysplasia of the hip (DDH) affects 4.33% of newborns in the Tesanj region. Early detection through arthrosonography is crucial for timely, non-operative treatment of hip developmental disorders.

Area of Science:

  • Pediatrics
  • Orthopedics
  • Developmental Biology

Background:

  • Developmental dysplasia of the hip (DDH) is a congenital condition affecting hip development, leading to functional disorders.
  • It is a dynamic and progressive disease impacting all hip joint elements.

Purpose of the Study:

  • To determine the clinical and statistical arthrosonographic representation of DDH in newborns in the Tesanj region.
  • To investigate the prevalence of DDH with and without identified risk factors.

Main Methods:

  • A study of 300 newborns in the Tesanj region examined between October 2008 and May 2009.
  • Arthrosonography using the Graf method was employed for diagnosis.

Main Results:

  • DDH was diagnosed in 4.33% of the newborns studied.
  • Including borderline cases (Graf type I), the incidence rose to 10.66%.
  • Nearly half of the infants (141) had at least one risk factor, with positive family history and natural birth being notable.

Conclusions:

  • Early detection of DDH in newborns is critical for effective, non-traumatic therapeutic interventions.
  • Timely treatment reduces the need for operative procedures and minimizes secondary complications.
  • The study highlights the importance of screening for developmental hip disorders in newborns, particularly those with risk factors.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Tetanus01:29

Tetanus

Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...